Graph (Graph)
Patients with Thrombocytosis Secondary to Myeloproliferative Disorders were monitored for Mean Platelet Count during Anagrelide Therapy over 208 weeks. The chart shows the platelet count fluctuating between 1200 and 2900. The number of subjects ranged from 923 at the start to 55 by the end of the treatment period.*